The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Acne Medication Market Research Report 2024

Global Acne Medication Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1413680

No of Pages : 94

Synopsis

Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

The global Acne Medication market was valued at US$ 3616.6 million in 2023 and is anticipated to reach US$ 4592.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Acne Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acne Medication.

Report Scope

The Acne Medication market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acne Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acne Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Stiefel
  • GALDERMA
  • VALEANT
  • Allergan
  • TEVA
  • Mylan
  • Mayne Pharma
  • HUAPONT PHARM
  • SPH
  • SUN PHARMA

Segment by Type

  • Topical Medication
  • Oral Medication

Segment by Application

  • Hospital Pharmacies
  • Drugstore
  • Online Retail
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acne Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acne Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Acne Medication Market Overview
1.1 Product Overview and Scope of Acne Medication
1.2 Acne Medication Segment by Type
1.2.1 Global Acne Medication Market Value Comparison by Type (2024-2030)
1.2.2 Topical Medication
1.2.3 Oral Medication
1.3 Acne Medication Segment by Application
1.3.1 Global Acne Medication Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Drugstore
1.3.4 Online Retail
1.3.5 Others
1.4 Global Acne Medication Market Size Estimates and Forecasts
1.4.1 Global Acne Medication Revenue 2019-2030
1.4.2 Global Acne Medication Sales 2019-2030
1.4.3 Global Acne Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Acne Medication Market Competition by Manufacturers
2.1 Global Acne Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Acne Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Acne Medication Average Price by Manufacturers (2019-2024)
2.4 Global Acne Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acne Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acne Medication, Product Type & Application
2.7 Acne Medication Market Competitive Situation and Trends
2.7.1 Acne Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acne Medication Players Market Share by Revenue
2.7.3 Global Acne Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acne Medication Retrospective Market Scenario by Region
3.1 Global Acne Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Acne Medication Global Acne Medication Sales by Region: 2019-2030
3.2.1 Global Acne Medication Sales by Region: 2019-2024
3.2.2 Global Acne Medication Sales by Region: 2025-2030
3.3 Global Acne Medication Global Acne Medication Revenue by Region: 2019-2030
3.3.1 Global Acne Medication Revenue by Region: 2019-2024
3.3.2 Global Acne Medication Revenue by Region: 2025-2030
3.4 North America Acne Medication Market Facts & Figures by Country
3.4.1 North America Acne Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Acne Medication Sales by Country (2019-2030)
3.4.3 North America Acne Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acne Medication Market Facts & Figures by Country
3.5.1 Europe Acne Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Acne Medication Sales by Country (2019-2030)
3.5.3 Europe Acne Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acne Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Acne Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Acne Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Acne Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acne Medication Market Facts & Figures by Country
3.7.1 Latin America Acne Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Acne Medication Sales by Country (2019-2030)
3.7.3 Latin America Acne Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acne Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Acne Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Acne Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Acne Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Acne Medication Sales by Type (2019-2030)
4.1.1 Global Acne Medication Sales by Type (2019-2024)
4.1.2 Global Acne Medication Sales by Type (2025-2030)
4.1.3 Global Acne Medication Sales Market Share by Type (2019-2030)
4.2 Global Acne Medication Revenue by Type (2019-2030)
4.2.1 Global Acne Medication Revenue by Type (2019-2024)
4.2.2 Global Acne Medication Revenue by Type (2025-2030)
4.2.3 Global Acne Medication Revenue Market Share by Type (2019-2030)
4.3 Global Acne Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Acne Medication Sales by Application (2019-2030)
5.1.1 Global Acne Medication Sales by Application (2019-2024)
5.1.2 Global Acne Medication Sales by Application (2025-2030)
5.1.3 Global Acne Medication Sales Market Share by Application (2019-2030)
5.2 Global Acne Medication Revenue by Application (2019-2030)
5.2.1 Global Acne Medication Revenue by Application (2019-2024)
5.2.2 Global Acne Medication Revenue by Application (2025-2030)
5.2.3 Global Acne Medication Revenue Market Share by Application (2019-2030)
5.3 Global Acne Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Stiefel
6.1.1 Stiefel Corporation Information
6.1.2 Stiefel Description and Business Overview
6.1.3 Stiefel Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stiefel Acne Medication Product Portfolio
6.1.5 Stiefel Recent Developments/Updates
6.2 GALDERMA
6.2.1 GALDERMA Corporation Information
6.2.2 GALDERMA Description and Business Overview
6.2.3 GALDERMA Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GALDERMA Acne Medication Product Portfolio
6.2.5 GALDERMA Recent Developments/Updates
6.3 VALEANT
6.3.1 VALEANT Corporation Information
6.3.2 VALEANT Description and Business Overview
6.3.3 VALEANT Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 VALEANT Acne Medication Product Portfolio
6.3.5 VALEANT Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allergan Acne Medication Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 TEVA
6.5.1 TEVA Corporation Information
6.5.2 TEVA Description and Business Overview
6.5.3 TEVA Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TEVA Acne Medication Product Portfolio
6.5.5 TEVA Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Acne Medication Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Mayne Pharma
6.6.1 Mayne Pharma Corporation Information
6.6.2 Mayne Pharma Description and Business Overview
6.6.3 Mayne Pharma Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mayne Pharma Acne Medication Product Portfolio
6.7.5 Mayne Pharma Recent Developments/Updates
6.8 HUAPONT PHARM
6.8.1 HUAPONT PHARM Corporation Information
6.8.2 HUAPONT PHARM Description and Business Overview
6.8.3 HUAPONT PHARM Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HUAPONT PHARM Acne Medication Product Portfolio
6.8.5 HUAPONT PHARM Recent Developments/Updates
6.9 SPH
6.9.1 SPH Corporation Information
6.9.2 SPH Description and Business Overview
6.9.3 SPH Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SPH Acne Medication Product Portfolio
6.9.5 SPH Recent Developments/Updates
6.10 SUN PHARMA
6.10.1 SUN PHARMA Corporation Information
6.10.2 SUN PHARMA Description and Business Overview
6.10.3 SUN PHARMA Acne Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SUN PHARMA Acne Medication Product Portfolio
6.10.5 SUN PHARMA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acne Medication Industry Chain Analysis
7.2 Acne Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acne Medication Production Mode & Process
7.4 Acne Medication Sales and Marketing
7.4.1 Acne Medication Sales Channels
7.4.2 Acne Medication Distributors
7.5 Acne Medication Customers
8 Acne Medication Market Dynamics
8.1 Acne Medication Industry Trends
8.2 Acne Medication Market Drivers
8.3 Acne Medication Market Challenges
8.4 Acne Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’